A Long-Term Pilot Study of Mindfulness-Based Cognitive Therapy for Subjective Well-Being Among Healthy Individuals in Comparison with Clinical Samples.

common mental disorders feasibility mindfulness-based cognitive therapy subjective well-being

Journal

Psychology research and behavior management
ISSN: 1179-1578
Titre abrégé: Psychol Res Behav Manag
Pays: New Zealand
ID NLM: 101514563

Informations de publication

Date de publication:
2021
Historique:
received: 02 05 2021
accepted: 21 08 2021
entrez: 22 10 2021
pubmed: 23 10 2021
medline: 23 10 2021
Statut: epublish

Résumé

Mindfulness-based cognitive therapy (MBCT) could be an intervention for improving subjective well-being among healthy individuals (HIs). However, MBCT studies for HIs to improve their subjective well-being are rare. The aim of this study was to report the feasibility, safety and effectiveness of MBCT for HIs in comparison with clinical samples. We conducted a single-arm, pre-post comparison pilot study offering MBCT to both HIs and people with common mental disorders. Twenty-four participants in total were included in the study. Eight weekly two-hour sessions with six monthly boosters were offered to all participants. Assessment was carried out at baseline, week 4, 8, and during follow-up. The 5-item World Health Organization Well-Being Index (WHO-5) was the primary clinical outcome measure. The results showed the MBCT is sufficiently safe and would be more feasible in HIs compared to in clinical samples (attendance rate: 81.5% vs 61.3%, p=0.06). Although Satisfaction with Life Scale, the other scale of subjective well-being used, improved significantly at week 20 (p=0.01), no significant improvement was seen in WHO-5. The results of the sub-group analysis revealed WHO-5 improved significantly at week 8 and 32 among the subjects whose baseline scores began in the lower half. MBCT is sufficiently safe and would be more feasible with HIs compared to the clinical samples. In designing randomized controlled trials, selecting HIs with lower subjective well-being would be reasonable to minimize the "ceiling effect" on outcomes.

Identifiants

pubmed: 34675705
doi: 10.2147/PRBM.S318460
pii: 318460
pmc: PMC8518140
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1655-1664

Informations de copyright

© 2021 Sado et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Biol Psychiatry. 2003 Sep 1;54(5):573-83
pubmed: 12946886
PLoS One. 2014 Oct 23;9(10):e111191
pubmed: 25340520
Epidemiology. 2007 Nov;18(6):805-35
pubmed: 18049195
Front Psychol. 2015 Jan 06;5:1504
pubmed: 25610410
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
J Pers Assess. 1985 Feb;49(1):71-5
pubmed: 16367493
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Occup Environ Med. 2003 Feb;45(2):156-74
pubmed: 12625231
Appl Psychol Health Well Being. 2017 Jul;9(2):133-167
pubmed: 28707767
Int Psychogeriatr. 2007 Feb;19(1):77-88
pubmed: 16970832
J Consult Clin Psychol. 2000 Aug;68(4):615-23
pubmed: 10965637
Depress Anxiety. 2003;18(2):76-82
pubmed: 12964174
Psychiatry Clin Neurosci. 2020 Feb;74(2):132-139
pubmed: 31774604
Front Psychol. 2018 Oct 08;9:1855
pubmed: 30349493
PLoS One. 2018 Dec 4;13(12):e0208034
pubmed: 30513087
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Consult Clin Psychol. 2008 Dec;76(6):966-78
pubmed: 19045965
BMC Psychiatry. 2008 Sep 30;8:85
pubmed: 18826581
Assessment. 2006 Mar;13(1):27-45
pubmed: 16443717
Shinrigaku Kenkyu. 2014 Apr;85(1):50-9
pubmed: 24804430
Health Econ. 2002 Jun;11(4):341-53
pubmed: 12007165
Psychol Inq. 2015 Oct 1;26(4):293-314
pubmed: 27087765
Lancet. 2015 Feb 14;385(9968):640-648
pubmed: 25468152
J Psychosom Res. 2007 May;62(5):589-94
pubmed: 17467414

Auteurs

Mitsuhiro Sado (M)

Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
Center for Stress Research, Keio University, Shinjuku, Tokyo, Japan.

Teppei Kosugi (T)

Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, Japan.

Akira Ninomiya (A)

Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
Center for Stress Research, Keio University, Shinjuku, Tokyo, Japan.

Sunre Park (S)

Faculty of Nursing and Medicine Care, Keio University, Shinjuku, Tokyo, Japan.
Palliative Care Center, Keio University Hospital, Shinjuku, Tokyo, Japan.

Daisuke Fujisawa (D)

Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
Palliative Care Center, Keio University Hospital, Shinjuku, Tokyo, Japan.
Division of Patient Safety, Keio University Hospital, Shinjuku, Tokyo, Japan.

Maki Nagaoka (M)

Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, Japan.

Masaru Mimura (M)

Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
Center for Stress Research, Keio University, Shinjuku, Tokyo, Japan.

Classifications MeSH